Anca Clabbers

发表

Comparison of the in vitro and in vivo stability of a succinimide intermediate observed on a therapeutic IgG1 molecule

D. Ouellette, Chris Chumsae, Anca Clabbers, 2013, mAbs.

Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain

Junhua Pan, Anca Clabbers, I. Correia, 2021, Science.

Purification and kinetic characterization of recombinant human mitogen-activated protein kinase kinase kinase COT and the complexes with its cellular partner NF-kappa B1 p105.

Kevin M. Clark, Anca Clabbers, N. Wishart, 2005, Archives of biochemistry and biophysics.

Discovery of thieno[2,3-c]pyridines as potent COT inhibitors.

R. Dixon, Anca Clabbers, C. Barberis, 2008, Bioorganic & medicinal chemistry letters.

Comparative analysis of various in vitro COT kinase assay formats and their applications in inhibitor identification and characterization.

Anca Clabbers, Yajun Xu, R. Talanian, 2006, Analytical biochemistry.

Identification of a selective thieno[2,3-c]pyridine inhibitor of COT kinase and TNF-alpha production.

R. Dixon, Anca Clabbers, A. Salmeron, 2009, Bioorganic & Medicinal Chemistry Letters.

A global benchmark study using affinity-based biosensors.

Yang Liu, Olan Dolezal, Eileen Lafer, 2009, Analytical biochemistry.

Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin

Sahana Bose, Anca Clabbers, T. Ghayur, 2007, Nature Biotechnology.

Generation and characterization of ABBV642, a dual variable domain immunoglobulin molecule (DVD-Ig) that potently neutralizes VEGF and PDGF-BB and is designed for the treatment of exudative age-related macular degeneration

Anca Clabbers, T. Ghayur, L. Benatuil, 2017, mAbs.